Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience
Authors
Keywords
-
Journal
WORLD JOURNAL OF UROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-06
DOI
10.1007/s00345-021-03899-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours
- (2021) Carsten-Henning Ohlmann et al. Scientific Reports
- Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy
- (2020) Antoin Douglawi et al. JOURNAL OF UROLOGY
- Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer
- (2020) Harsha R. Mittakanti et al. Translational Andrology and Urology
- Economic evaluation of robot-assisted radical prostatectomy compared to open radical prostatectomy for prostate cancer treatment in Ontario, Canada
- (2020) Anna Parackal et al. CUAJ-Canadian Urological Association Journal
- Robotic-Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer
- (2020) Andreas Hiester et al. JOURNAL OF UROLOGY
- Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors
- (2020) Raj Bhanvadia et al. WORLD JOURNAL OF UROLOGY
- Radical cystectomy—what is the optimal surgical approach?
- (2020) Gregory J. Nason et al. Translational Andrology and Urology
- National trends and disparities of minimally invasive surgery for localized renal cancer, 2010 to 2015
- (2019) Leilei Xia et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance
- (2019) Robert J. Hamilton et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
- (2019) Klaus-Peter Dieckmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Differences in utilization-trend and time changes of peri-operative outcomes of robotic and open radical cystectomy between American and European selected centers: an international multicenter collaboration
- (2019) Stefania Zamboni et al. BJU INTERNATIONAL
- Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline
- (2019) Andrew Stephenson et al. JOURNAL OF UROLOGY
- The Role of Robotic Retroperitoneal Lymph Node Dissection for Testis Cancer
- (2019) Zachary Klaassen et al. UROLOGIC CLINICS OF NORTH AMERICA
- Altering the Natural History of Surgical Relapse in Testicular Cancer: Suboptimal Surgery and Pneumoperitoneum
- (2019) Joel Sheinfeld et al. EUROPEAN UROLOGY
- Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer
- (2019) Adam C. Calaway et al. EUROPEAN UROLOGY
- Recurrence After Robotic Retroperitoneal Lymph Node Dissection Raises More Questions than Answers
- (2019) James Porter et al. EUROPEAN UROLOGY
- Re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.05.031
- (2019) Gregory J. Nason et al. EUROPEAN UROLOGY
- Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes
- (2019) Nicholas R. Rocco et al. WORLD JOURNAL OF UROLOGY
- Active surveillance in stage 1 disease
- (2019) Gregory J. Nason et al. CURRENT OPINION IN UROLOGY
- Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2019) Timothy Gilligan et al. Journal of the National Comprehensive Cancer Network
- Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center
- (2018) Nicola Nicolai et al. JOURNAL OF UROLOGY
- Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor
- (2018) Ricardo Leão et al. JOURNAL OF UROLOGY
- Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
- (2018) C. Overs et al. WORLD JOURNAL OF UROLOGY
- Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
- (2018) Pedro T. Ramirez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
- (2018) Alexander Melamed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer
- (2017) Shane M. Pearce et al. EUROPEAN UROLOGY
- Patient body image, self-esteem, and cosmetic results of minimally invasive robotic cardiac surgery
- (2017) Taner İyigün et al. International Journal of Surgery
- Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique
- (2016) Sevan Stepanian et al. EUROPEAN UROLOGY
- Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients
- (2016) Nicola Nicolai et al. JOURNAL OF ENDOUROLOGY
- Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience
- (2016) Mohamed H. Kamel et al. JOURNAL OF ENDOUROLOGY
- Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study
- (2016) John W Yaxley et al. LANCET
- A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer
- (2015) Kelly T. Harris et al. BJU INTERNATIONAL
- Guidelines on Testicular Cancer: 2015 Update
- (2015) Peter Albers et al. EUROPEAN UROLOGY
- Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients
- (2014) Scott M. Cheney et al. BJU INTERNATIONAL
- Port Site Metastasis after Surgery for Renal Cell Carcinoma: Harbinger of Future Metastasis
- (2014) Joseph Song et al. JOURNAL OF UROLOGY
- Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer – a single center analysis
- (2012) Jonas Busch et al. BMC Urology
- Non–Risk-Adapted Surveillance in Clinical Stage I Nonseminomatous Germ Cell Tumors: The Princess Margaret Hospital’s Experience
- (2010) Jeremy F. Sturgeon et al. EUROPEAN UROLOGY
- Management of Disseminated Nonseminomatous Germ Cell Tumors With Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery
- (2009) Christian Kollmannsberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?
- (2009) Yaron Ehrlich et al. JOURNAL OF CLINICAL ONCOLOGY
- Laparoscopic Retroperitoneal Lymph Node Dissection: Does It Still Have a Role in the Management of Clinical Stage I Nonseminomatous Testis Cancer? A European Perspective
- (2008) Jens J. Rassweiler et al. EUROPEAN UROLOGY
- Clinical Outcome and Predictors of Survival in Late Relapse of Germ Cell Tumor
- (2008) David S. Sharp et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started